Over 3 billion people of the world’s population of 7.6 billion live in rural areas, 90 percent of them in Asia and Africa, according to United Nations estimates. The two continents have the most lower and middle-income countries (LMIC), which the World Bank defines as states with a GNI (Gross National Income) per capita of $1,005 or less and between $1,006 and $3,955, respectively.
One of the major challenges many of these countries face is access to healthcare, where hard-to-reach rural areas bear the brunt of the inequality. In some cases, even where health clinics are relatively accessible, they often offer lower quality care compared to those in urban areas. ParaSight The story of OLO began two years ago with the introduction of Parasight – a breakthrough diagnostic solution for the quick and accurate detection of malaria using digital fluorescent microscopy and computer vision algorithms. Healthcare providers have been searching for years for an alternative to manual microscopy, a time consuming method that requires trained personnel.
Parasight offers an accurate, cost-effective and simple-to-use solution that delivers extraordinary diagnostic accuracy (sensitivity/specificity of more than 98% at 50 par/µL) with minimal training or maintenance.
To date, Parasight has been sold to healthcare providers in 24 countries across Asia, Africa, and Europe, with more than 600,000 malaria tests shipped.
OLO. The first complete blood count device for point-of-care
Forget waiting for days to receive lab results. With OLO, doctors will have the answers they need within a single office visit.
EfA is developing a handheld programmable device that performs automated blood analysis and diagnostics at the point of care.
RevDx (Revolution Diagnostics) is meant for anyplace without reliable access to a lab, electricity or Internet connection, says founder Yoel Ezra, former chief commander of an IDF technological unit.
The digital platform — combining opto-mechanics, electrochemistry and bioengineering technologies — will initially be programmed to do a blood count and diagnose malaria, two major identified needs. Future applications could support additional blood and urine analyses.
A programmable lab-on-hand for automated blood tests and infectious disease diagnostics, enabling the appropriate treatment at the right time
From on-the-spot accurate diagnostic to a real-time mapping and data analytics
Tytocare, a telehealth company that developed hand-held medical check-up devices. Tytocare’s devices don’t do bloodwork but can examine the ears, throat, heart, lung, abdomen, and skin, and measure heart rate and temperature so a doctor can issue a diagnosis remotely. Founded in 2012, it has so far raised $45 million and has partnered with 25 health systems in the US, where it is looking to expand.
Sonorapy is developing a technology to replace standard diagnostic blood tests with a noninvasive soundwave diagnostic tool to detect pathogens (viruses or bacteria) from a single blood.
A unique algorithm will identify the pathogen using a massive database of harmonic resonance peaks for each disease. In seconds, easy-to-read test results will be available at the point of care.
Sonorapy’s device theoretically could even scan the patient’s body rather than a blood sample, making the diagnostic process 100 percent noninvasive.